MedPath

Timing of Renal Replacement Therapy In Mechanically Ventilated Patients

Not Applicable
Completed
Conditions
Timing of RRT in Mechanically Ventilated Patients
Registration Number
NCT05382598
Lead Sponsor
Alexandria University
Brief Summary

This is a randomized controlled study that will be conducted on acute kidney injury (AKI) patients, who are mechanically ventilated, to assess the impact of implementation of early renal replacement therapy (RRT) compared to late RRT on patients outcome.

Detailed Description

The study subjects will be randomly divided into two groups (arms).

The first one will be patients who will receive early renal replacement therapy (RRT) according to predefined criteria that will be illustrated later.

The other group of patients will be those who receive late RRT according to the absolute indications of emergency hemodialysis i.e. severe hyperkalemia, life-threatening acidosis, uremic encephalopathy or pericarditis in addition to intractable pulmonary edema.

Appropriate randomization technique will be applied. A computer-based program will be used to perform the randomization procedure.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
94
Inclusion Criteria
  • All patients must be on invasive mechanical ventilation.
  • Patients in AKI stage 2 , according to KDIGO classification.
  • Recruited subjects will include either those who present with AKI on their ICU admission or those who develop AKI during their ICU stay
Exclusion Criteria
  • Those who are known to be in grade 5 CKD according to KDIGO classification. All other grades of CKD from 1 to 4 will be included only if they develop or present with stage 2 AKI on top of their CKD grade
  • Those who develop AKI due to obstructive or traumatic causes.
  • Patients with septic shock who are on high doses of vasopressors or inotropes (norepinephrine infusion more than 1 mcg/kg/minute, dopamine or dobutamine infusion more than 5 mcg/kg/minute).
  • Pregnant females

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
mortality28 days

ICU mortality

Weaning of mechanical ventilationthrough study completion, an average of 1 year

duration of mechanical ventilation

ICU length of staythrough study completion, an average of 1 year

Duration of ICU stay

Secondary Outcome Measures
NameTimeMethod
Renal functions on discharge from ICUthrough study completion, an average of 1 year

creatinine level on day of discharge from ICU

RRT dependencyfor more than three months

Persistent need for renal replacement therapy for at least two sessions per week

Trial Locations

Locations (1)

Alexandria Faculty of Medicine

🇪🇬

Alexandria, Alexandria Governorate, Egypt

Alexandria Faculty of Medicine
🇪🇬Alexandria, Alexandria Governorate, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.